Sii

A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.

Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.

Praising the work done by the founder of the Serum Institute of India (SII), in the field of vaccine production, founder of Nationalist Congress Party (NCP) Sharad Pawar demanded that Cyrus Poonawalla be honoured with the Bharat Ratna award.

Dr Cyrus Poonawalla, Chairman and Managing Director of the city-based vaccine manufacturer Serum Institute of India (SII), suffered mild cardiac arrest and underwent an angioplasty procedure in a hospital here, doctors said on Friday.

Study in India Portal is a dedicated website that will provide comprehensive information about the Indian Higher Education Institutions (HEIs).

The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar Poonawalla.

A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.

The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said on Thursday.

China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.

The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.

The Serum Institute of India has offered two crore doses of Covishield vaccine to the central government free of cost amid a rise in COVID-19 cases in some countries, official sources said today.

Raising concern on the rising COVID-19 cases in neighbouring China, Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday asked the people not to panic because of India's "excellent vaccination coverage and track record".

In a major breakthrough, the Pune Police said today that they have arrested seven accused in the cheating case in which Serum Institute of India (SII) was cheated of over Rs 1.01 crore.

Serum Institute of India (SII) had to defer HPV vaccine production by two years due to the focus on Covid, and will start supplying small quantities of the dose to the Indian government in early 2023, a top official has said.

A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.

Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.

Praising the work done by the founder of the Serum Institute of India (SII), in the field of vaccine production, founder of Nationalist Congress Party (NCP) Sharad Pawar demanded that Cyrus Poonawalla be honoured with the Bharat Ratna award.

Dr Cyrus Poonawalla, Chairman and Managing Director of the city-based vaccine manufacturer Serum Institute of India (SII), suffered mild cardiac arrest and underwent an angioplasty procedure in a hospital here, doctors said on Friday.

Study in India Portal is a dedicated website that will provide comprehensive information about the Indian Higher Education Institutions (HEIs).

The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar Poonawalla.

A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.

The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said on Thursday.

China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.

The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.

The Serum Institute of India has offered two crore doses of Covishield vaccine to the central government free of cost amid a rise in COVID-19 cases in some countries, official sources said today.

Raising concern on the rising COVID-19 cases in neighbouring China, Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday asked the people not to panic because of India's "excellent vaccination coverage and track record".

In a major breakthrough, the Pune Police said today that they have arrested seven accused in the cheating case in which Serum Institute of India (SII) was cheated of over Rs 1.01 crore.

Serum Institute of India (SII) had to defer HPV vaccine production by two years due to the focus on Covid, and will start supplying small quantities of the dose to the Indian government in early 2023, a top official has said.